Загрузка...
Inflammatory bowel disease: towards a personalized medicine
The management of inflammatory bowel disease (IBD) has been transformed over the last two decades by the arrival of tumor necrosis factor (TNF) antagonist agents. Recently, alternative drugs have been approved, directed at leukocyte-trafficking molecules (vedolizumab) or other inflammatory cytokines...
Сохранить в:
| Опубликовано в: : | Therap Adv Gastroenterol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784543/ https://ncbi.nlm.nih.gov/pubmed/29383027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17745029 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|